AEON Biopharma (AEON) Earnings Date, Estimates & Call Transcripts → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free AEON Stock Alerts $1.60 -0.03 (-1.59%) (As of 01:55 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media Earnings SummaryLatest Earnings DateMar. 29EstimatedActual EPS (Mar. 29) -$0.71 Missed By -$0.71 Get AEON Biopharma Earnings AlertsEnter your email address below to receive the latest news and earnings results for AEON and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAEON Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AEON Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Monetary GoldTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. AEON Biopharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.31)($0.31)($0.31)Q2 20241($0.31)($0.31)($0.31)Q3 20241($0.32)($0.32)($0.32)Q4 20241($0.24)($0.24)($0.24)FY 20244($1.18)($1.18)($1.18)Q1 20251($0.29)($0.29)($0.29)Q2 20251($0.31)($0.31)($0.31)Q3 20251($0.32)($0.32)($0.32)Q4 20251($0.24)($0.24)($0.24)FY 20254($1.16)($1.16)($1.16)AEON Earnings Date and InformationAEON Biopharma last announced its quarterly earnings results on March 29th, 2024. The reported ($0.71) earnings per share for the quarter. AEON Biopharma has generated $0.00 earnings per share over the last year. Earnings for AEON Biopharma are expected to grow in the coming year, from ($1.18) to ($1.16) per share. Read More AEON Biopharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript3/29/2024Q4 2023-($0.71)($0.71)($0.71)-- AEON Biopharma Earnings - Frequently Asked Questions When did AEON Biopharma announce their last quarterly earnings? AEON Biopharma (NASDAQ:AEON) last announced its quarterly earning data on Friday, March 29, 2024. Learn more on AEON's earnings history. How much profit does AEON Biopharma generate each year? AEON Biopharma (NASDAQ:AEON) has a recorded net income of -$36.63 million. AEON has generated $0.00 earnings per share over the last four quarters. What is AEON Biopharma's EPS forecast for next year? AEON Biopharma's earnings are expected to grow from ($1.18) per share to ($1.16) per share in the next year. More Earnings Resources from MarketBeat Related Companies: CKPT Earnings CALC Earnings KZR Earnings EGRX Earnings ANVS Earnings IMMX Earnings RPHM Earnings CELU Earnings ALRN Earnings EQ Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong Earnings This page (NASDAQ:AEON) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersDoes this make you sick?Allegiance GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldBill Clinton Backing Biden Replacement???The Freeport SocietyTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Monetary GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingTop 5 Tech Stocks to Buy for 2024Daily Market AlertsTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AEON Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.